Indexed keywords
2 [3 OXO 1 (BENZENE 4 SULFONYL) 1,2,3,4 4H QUINOXALIN 2 YL] N [4 (METHYLOXYFORMYL)PHENYL]ACETAMIDE;
2 [3 OXO 1 (TOLUENE 4 SULFONYL) 1,2,3,4 4H QUINOXALIN 2 YL] N PHENYLACETAMIDE;
3 (TOLUENE 4 SULFONYLAMINO)PROPIONIC ACID ETHYL ESTER;
[1 [[2,4 DICHLORO 3 [(2,4 DIMETHYLQUINOLIN 8 YL)OXY]METHYL]PHENYL]SULFONYL] N [3 [[4 (AMINOIMINOMETHYL)PHENYL]CARBONYLAMINO]PROPYL]PYRROLIDINECARBOXAMIDE;
ANATIBANT;
BRADYKININ B1 RECEPTOR;
BRADYKININ B1 RECEPTOR ANTAGONIST;
BRADYKININ B2 RECEPTOR;
BRADYKININ B2 RECEPTOR ANTAGONIST;
BRADYZIDE;
ETHYL 2 [3 [(1 PHENYLSULFONYL 1H INDOL 2 YL)CARBONYL] 1,4,5,6 TETRAHYDROPYRIDIN 1 YL]ETHANOATE;
N (4 ETHOXYPHENYL) 3 (TOLUENE 4 SULFONYLAMINO)PROPIONAMIDE;
N [2 [4 (4,5 DIHYDRO 1H IMIDAZOL 2 YL)PHENYL]ETHYL] 2 [1 (2 NAPHTHYLSULFONYL) 3 OXO 1,2,3,4 TETRAHYDROQUINOXALIN 2 YL]ACETAMIDE;
UNCLASSIFIED DRUG;
AORTA;
CONFERENCE PAPER;
DATA BASE;
IC 50;
MOLECULE;
MUSCLE CONTRACTILITY;
NONHUMAN;
PHARMACOPHORE;
PRIORITY JOURNAL;
RABBIT;
RADIOASSAY;
RECEPTOR BINDING;
SMOOTH MUSCLE FIBER;
ACETANILIDES;
ANIMALS;
AORTA;
BINDING SITES;
BINDING, COMPETITIVE;
CELLS, CULTURED;
MOLECULAR STRUCTURE;
MUSCLE, SMOOTH;
PYRROLIDINES;
QUINOLINES;
QUINOXALINES;
RABBITS;
RECEPTOR, BRADYKININ B1;
RECEPTOR, BRADYKININ B2;
STRUCTURE-ACTIVITY RELATIONSHIP;
SULFONES;
THIOSEMICARBAZONES;
TOSYL COMPOUNDS;
ORYCTOLAGUS CUNICULUS;
1
22744440393
Non-peptide ligands for bradykinin receptors 1995-2004
Dziadulewicz, E.K. (2005). Non-peptide ligands for bradykinin receptors 1995-2004. Expert Opin. Ther. Patents 15, 829-859.
(2005)
Expert Opin. Ther. Patents
, vol.15
, pp. 829-859
Dziadulewicz, E.K.1
4
20244362528
Binding modes of dihydroquinoxalinones in a homology model of bradykinin receptor 1
Ha, S.N., Hey, P.J., Ransom, R.W., Harrell, C.M. Jr., Murphy, K.L., Chang, R., Chen, T.B., Su, D.S., Markowitz, M.K., Bock, M.G., et al. (2005). Binding modes of dihydroquinoxalinones in a homology model of bradykinin receptor 1. Biochem. Biophys. Res. Commun. 331, 159-166.
(2005)
Biochem. Biophys. Res. Commun.
, vol.331
, pp. 159-166
Ha, S.N.1
Hey, P.J.2
Ransom, R.W.3
Harrell Jr., C.M.4
Murphy, K.L.5
Chang, R.6
Chen, T.B.7
Su, D.S.8
Markowitz, M.K.9
Bock, M.G.10
6
23244449648
1 antagonists: SAR studies in the 2,3-diaminopyridine series
1 antagonists: SAR studies in the 2,3-diaminopyridine series. Bioorg. Med. Chem. Lett. 15, 3925-3929.
(2005)
Bioorg. Med. Chem. Lett.
, vol.15
, pp. 3925-3929
Kuduk, S.D.1
Chang, R.K.2
Ng, C.3
Murphy, K.L.4
Ransom, R.W.5
Tang, C.6
Prueksaritanont, T.7
Freidinger, R.M.8
Pettibone, D.J.9
Bock, M.G.10
7
14144251086
International Union of Pharmacology. XLV. Classification of the kinin receptor family: From molecular mechanisms to pathophysiological consequences
Leeb-Lundberg, L.M.F., Marceau, F., Müller-Esterl, W., Pettibone, D.J., and Zuraw, B.L. (2005). International Union of Pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol. Rev. 57, 27-77.
(2005)
Pharmacol. Rev.
, vol.57
, pp. 27-77
Leeb-Lundberg, L.M.F.1
Marceau, F.2
Müller-Esterl, W.3
Pettibone, D.J.4
Zuraw, B.L.5
9
6444236841
Bradykinin receptor ligands: Therapeutic perspectives
Marceau, F. and Regoli, D. (2004). Bradykinin receptor ligands: therapeutic perspectives. Nat. Rev. Drug Discov. 3, 845-852.
(2004)
Nat. Rev. Drug Discov.
, vol.3
, pp. 845-852
Marceau, F.1
Regoli, D.2
12
0035798651
2 bradykinin receptor. Modeling of non-peptidic ligand action and comparison to the rhodopsin structure
2 bradykinin receptor. Modeling of non-peptidic ligand action and comparison to the rhodopsin structure. J. Biol. Chem. 276, 41100-41111.
(2001)
J. Biol. Chem.
, vol.276
, pp. 41100-41111
Marie, J.1
Richard, E.2
Pruneau, D.3
Paquet, J.L.4
Siatka, C.5
Larguier, R.6
Ponce, C.7
Vassault, P.8
Groblewski, T.9
Maigret, B.10
Bonnafous, J.C.11
15
0032748935
2 receptor antagonist
2 receptor antagonist. Immunopharmacology 43, 187-194.
(1999)
Immunopharmacology
, vol.43
, pp. 187-194
Pruneau, D.1
Paquet, J.L.2
Luccarini, J.M.3
Defrêne, E.4
Fouchet, C.5
Franck, R.M.6
Loillier, B.7
Robert, C.8
Bélichard, P.9
Duclos, H.10
Cremers, B.11
Dodey, P.12
16
19344367480
1 receptor antagonist
1 receptor antagonist. Eur. J. Pharmacol. 499, 77-84.
(2004)
Eur. J. Pharmacol.
, vol.499
, pp. 77-84
Ransom, R.W.1
Harrell, C.M.2
Reiss, D.R.3
Murphy, K.L.4
Chang, R.S.5
Hess, J.F.6
Miller, P.J.7
O'Malley, S.S.8
Hey, P.J.9
Kunapuli, P.10
17
4444315533
1 receptor based on a 2-alkylamino-5-sulfamoylbenza-mide core
1 receptor based on a 2-alkylamino-5- sulfamoylbenza-mide core. J. Med. Chem. 47, 4642-4644.
(2004)
J. Med. Chem.
, vol.47
, pp. 4642-4644
Ritchie, T.J.1
Dziadulewicz, E.K.2
Culshaw, A.J.3
Muller, W.4
Burgess, G.M.5
Bloomfield, G.C.6
Drake, G.S.7
Dunstan, A.R.8
Beattie, D.9
Hughes, G.A.10
19
0038546886
1 receptor antagonist
1 receptor antagonist. J. Am. Chem. Soc. 125, 7516-7517.
(2003)
J. Am. Chem. Soc.
, vol.125
, pp. 7516-7517
Su, D.S.1
Markowitz, M.K.2
Dipardo, R.M.3
Murphy, K.L.4
Harrell, C.M.5
O'Malley, S.S.6
Ransom, R.W.7
Chang, R.S.8
Ha, S.9
Hess, F.J.10
20
8844253298
1 receptor occupancy studies
1 receptor occupancy studies. Bioorg. Med. Chem. Lett. 14, 6045-6048.
(2004)
Bioorg. Med. Chem. Lett.
, vol.14
, pp. 6045-6048
Su, D.S.1
Markowitz, M.K.2
Murphy, K.L.3
Wan, B.L.4
Zrada, M.M.5
Harrell, C.M.6
O'Malley, S.S.7
Hess, J.F.8
Ransom, R.W.9
Chang, R.S.10